The role of calpain in oncotic cell death.

Numerous lines of evidence demonstrate that calpains, a family of 14 Ca(2+)-activated neutral cysteine proteases, are involved in oncotic cell death in a variety of models. At this time, the biochemistry of most calpains and the specific roles of different calpains in physiology and pathology remain to be determined. A number of calpain substrates have been identified in cellular systems, including cytoskeletal proteins, and recent studies suggest that calpains mediate the increase in plasma membrane permeability to ions and the progressive breakdown of the plasma membrane observed in oncosis through the proteolysis of cystokeletal and plasma membrane proteins. Further, a number of reports provide evidence that the mitochondrial dysfunction observed in oncosis may be mediated by a mitochondrial calpain of unknown identity. Finally, a number of diverse calpain inhibitors have been developed that show cytoprotective properties in cellular systems and in vivo following diverse insults. It is suggested that future research be directed toward elucidation of the role(s) of specific calpain isozymes in physiological and pathological conditions; identifying and linking specific calpain substrates with altered cellular functions; and developing cell-permeable, potent, isozyme-selective calpain inhibitors.

[1]  W. Lieberthal,et al.  Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. , 1998, American journal of physiology. Renal physiology.

[2]  S. Harwood,et al.  Calpain inhibitor I reduces the activation of nuclear factor-k B and organ injury / dysfunction in hemorrhagic shock , 2000 .

[3]  A. Wyllie,et al.  Apoptosis. The role of the endonuclease. , 1990, The American journal of pathology.

[4]  J. Tauskela,et al.  Selective coupling of μ‐calpain activation with the NMDA receptor is independent of translocation and autolysis in primary cortical neurons , 1998, Journal of neuroscience research.

[5]  K. Suzuki,et al.  Structure and physiological function of calpains. , 1997, The Biochemical journal.

[6]  M. Zoratti,et al.  The mitochondrial permeability transition. , 1995, Biochimica et biophysica acta.

[7]  E. Newcomb,et al.  Cleavage of Bax enhances its cell death function. , 2000, Experimental cell research.

[8]  G. Lynch,et al.  Translational suppression of calpain I reduces NMDA-induced spectrin proteolysis and pathophysiology in cultured hippocampal slices , 1995, Brain Research.

[9]  R. Bentley,et al.  Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. , 1999, Gastroenterology.

[10]  W. B. Reeves Effects of chloride channel blockers on hypoxic injury in rat proximal tubules. , 1997, Kidney international.

[11]  H. Kawasaki,et al.  Molecular cloning of the cDNA for the large subunit of the high-Ca2+-requiring form of human Ca2+-activated neutral protease. , 1988, Biochemistry.

[12]  M. Tamai,et al.  Possible mechanism for the decrease of mitochondrial aspartate aminotransferase activity in ischemic and hypoxic rat retinas. , 1999, Biochimica et Biophysica Acta.

[13]  W. Welte,et al.  Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore , 1996, FEBS letters.

[14]  R. Schnellmann,et al.  Depletion of endoplasmic reticulum calcium stores protects against hypoxia- and mitochondrial inhibitor-induced cellular injury and death. , 1997, Biochemical and biophysical research communications.

[15]  A. Wells,et al.  Ip-10 Inhibits Epidermal Growth Factor–Induced Motility by Decreasing Epidermal Growth Factor Receptor–Mediated Calpain Activity , 1999, The Journal of cell biology.

[16]  R. Schnellmann,et al.  Examination of the Mechanisms of Action of Diverse Cytoprotectants in Renal Cell Death , 1998, Toxicologic pathology.

[17]  L. Mandel,et al.  Decreased protein phosphorylation induced by anoxia in proximal renal tubules. , 1994, The American journal of physiology.

[18]  K. Wang,et al.  Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. , 2000, Biochemical and biophysical research communications.

[19]  J. Fox,et al.  Calpain Mediates Integrin-induced Signaling at a Point Upstream of Rho Family Members* , 1999, The Journal of Biological Chemistry.

[20]  H. Hori,et al.  Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases. , 1993, Journal of medicinal chemistry.

[21]  P. Zalewski,et al.  Ca2+/Mg(2+)-dependent nuclease: tissue distribution, relationship to inter-nucleosomal DNA fragmentation and inhibition by Zn2+. , 1991, Biochemical and biophysical research communications.

[22]  R. Schrier,et al.  Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. , 2000, American journal of physiology. Renal physiology.

[23]  J. Fox,et al.  Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa , 1993, The Journal of cell biology.

[24]  J. Wetzels,et al.  Rise in cytosolic Ca2+ and collapse of mitochondrial potential in anoxic, but not hypoxic, rat proximal tubules. , 1996, Journal of the American Society of Nephrology : JASN.

[25]  S. Cuzzocrea,et al.  Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. , 2001, Kidney international.

[26]  A. Halestrap,et al.  Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.

[27]  R. Smith,et al.  Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases. , 1992, The Biochemical journal.

[28]  R. Schnellmann,et al.  Extracellular acidosis and chloride channel inhibitors act in the late phase of cellular injury to prevent death. , 1996, The Journal of pharmacology and experimental therapeutics.

[29]  J. Lemasters V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[30]  T. Zalewska,et al.  Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  A. Rami,et al.  μ-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage , 2000, Brain Research.

[32]  K. Ishiguro,et al.  Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25* , 2000, The Journal of Biological Chemistry.

[33]  R. Ménard,et al.  Catalytic mechanism in papain family of cysteine peptidases. , 1994, Methods in enzymology.

[34]  H. Umezawa Chemistry of enzyme inhibitors of microbial origin , 1973, Pure and applied chemistry. Chimie pure et appliquee.

[35]  M. Lane,et al.  Mitotic Clonal Expansion during Preadipocyte Differentiation: Calpain-mediated Turnover of p27* , 2000, The Journal of Biological Chemistry.

[36]  G. Demartino,et al.  Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.

[37]  N. Peet,et al.  Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G. , 1990, Journal of medicinal chemistry.

[38]  H. Sorimachi,et al.  A novel aspect of calpain activation , 1998, FEBS letters.

[39]  B. Trump,et al.  Calcium‐mediated cell injury and cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  E. Melloni,et al.  Calcium-binding properties of human erythrocyte calpain. , 1997, The Biochemical journal.

[41]  M. Yaqoob,et al.  Modulation of hypoxia-induced calpain activity in rat renal proximal tubules. , 1996, Kidney international.

[42]  Luca Scorrano,et al.  Mitochondria and cell death. Mechanistic aspects and methodological issues. , 1999, European journal of biochemistry.

[43]  A. Magnússon,et al.  Calcium‐induced degradation of the Inositol (1,4,5)‐trisphosphate receptor/Ca2+‐channel , 1993, FEBS letters.

[44]  B. Trump,et al.  HgCl2-induced alteration of actin filaments in cultured primary rat proximal tubule epithelial cells labelled with fluorescein phalloidin , 1991, Cell Biology and Toxicology.

[45]  M. Sheetz,et al.  Loss of cytoskeletal support is not sufficient for anoxic plasma membrane disruption in renal cells. , 1997, The American journal of physiology.

[46]  Jeremy J. Flint,et al.  Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats , 2001 .

[47]  G. Lynch,et al.  Inhibition of proteolysis protects hippocampal neurons from ischemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Rabkin,et al.  Angiotensin II induced alteration of cyclic adenosine 3',5'-monophosphate generation in the hypertrophic myocardium of Dahl salt-sensitive rat on a high-salt diet. , 1994, Canadian journal of physiology and pharmacology.

[49]  T. Tsujinaka,et al.  Synthesis of a new cell penetrating calpain inhibitor (calpeptin). , 1988, Biochemical and biophysical research communications.

[50]  Y. Tsujimoto,et al.  BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Weinberg,et al.  Development of porous defects in plasma membranes of adenosine triphosphate-depleted Madin-Darby canine kidney cells and its inhibition by glycine. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[52]  M. Compton A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome , 1992, Cancer and Metastasis Reviews.

[53]  J. Schollmeyer Calpain II involvement in mitosis. , 1988, Science.

[54]  J. Lemasters,et al.  Glycine blocks opening of a death channel in cultured hepatic sinusoidal endothelial cells during chemical hypoxia , 2001, Cell Death and Differentiation.

[55]  R. Haworth,et al.  Relationship between configuration, function, and permeability in calcium-treated mitochondria. , 1976, The Journal of biological chemistry.

[56]  C. Camargo,et al.  Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Saido,et al.  Calpain inhibitor entrapped in liposome rescues ischemic neuronal damage , 1999, Brain Research.

[58]  M. Hori,et al.  Intracellular calcium level required for calpain activation in a single myocardial cell. , 2001, Journal of molecular and cellular cardiology.

[59]  M. Monden,et al.  Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. , 1996, Gastroenterology.

[60]  E. Shaw,et al.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. , 1988, The Biochemical journal.

[61]  R. Schrier,et al.  The nature of renal cell injury. , 1997, Kidney international.

[62]  R. Schrier,et al.  Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules. , 1999, Journal of the American Society of Nephrology : JASN.

[63]  G. Clifton,et al.  Subcellular Localization and Duration of μ-Calpain and m-Calpain Activity after Traumatic Brain Injury in the Rat: A Casein Zymography Study , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  G. Miller,et al.  Inhibitors of renal chloride transport do not block toxicant-induced chloride influx in the proximal tubule. , 1995, Toxicology letters.

[65]  K. Wang,et al.  Calpains mediate calcium and chloride influx during the late phase of cell injury. , 1997, The Journal of pharmacology and experimental therapeutics.

[66]  J. Powers,et al.  Novel Peptidyl α-Keto Amide Inhibitors of Calpains and Other Cysteine Proteases , 1996 .

[67]  P. Greer,et al.  Disruption of the Murine Calpain Small Subunit Gene, Capn4: Calpain Is Essential for Embryonic Development but Not for Cell Growth and Division , 2000, Molecular and Cellular Biology.

[68]  E. Melloni,et al.  Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization , 1996, FEBS letters.

[69]  J. Lemasters The mitochondrial permeability transition: from biochemical curiosity to pathophysiological mechanism. , 1998, Gastroenterology.

[70]  R. Schnellmann,et al.  Cytoprotective properties of novel nonpeptide calpain inhibitors in renal cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[71]  R. Nixon,et al.  Calpains and calpastatin in SH‐SY5Y neuroblastoma cells during retinoic acid‐induced differentiation and neurite outgrowth: Comparison with the human brain calpain system , 1997, Journal of neuroscience research.

[72]  L. Bourguignon,et al.  Selective down-regulation of IP(3)receptor subtypes by caspases and calpain during TNF alpha -induced apoptosis of human T-lymphoma cells. , 2000, Cell calcium.

[73]  R. Schnellmann,et al.  Diverse cytoprotectants prevent cell lysis and promote recovery of respiration and ion transport. , 1997, Biochemical and biophysical research communications.

[74]  D. E. Goll,et al.  Immunoaffinity purification of the calpains. , 2002, Protein expression and purification.

[75]  Kazuo Suzuki,et al.  Calpain Dissociates into Subunits in the Presence Ions , 1995 .

[76]  Changlian Zhu,et al.  Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.

[77]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[78]  G. Lynch,et al.  Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus , 1989, Brain Research.

[79]  E. Melloni,et al.  Modulation of the calpain autoproteolysis by calpastatin and phospholipids. , 1996, Biochemical and biophysical research communications.

[80]  Wenli Zhang,et al.  The Major Calpain Isozymes Are Long-lived Proteins , 1996, The Journal of Biological Chemistry.

[81]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[82]  M. Linnik,et al.  Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. , 1998, Stroke.

[83]  R. Schnellmann,et al.  Proteases in renal cell death: calpains mediate cell death produced by diverse toxicants. , 1998, Renal failure.

[84]  John Calvin Reed,et al.  Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion* , 2001, The Journal of Biological Chemistry.

[85]  M. Fehlings,et al.  Pretreatment with Calpain Inhibitor CEP‐4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord Injury , 2000, Journal of neurochemistry.

[86]  Alan Wells,et al.  Membrane Proximal ERK Signaling Is Required for M-calpain Activation Downstream of Epidermal Growth Factor Receptor Signaling* , 2001, The Journal of Biological Chemistry.

[87]  R. Doctor,et al.  Distribution of epithelial ankyrin (Ank3) spliceoforms in renal proximal and distal tubules. , 1998, American journal of physiology. Renal physiology.

[88]  T. Saido,et al.  Fodrin degradation and subcellular distribution of calpains after neonatal rat cerebral hypoxic-ischemia , 1995, Brain Research.

[89]  B. Pike,et al.  Regional calpain and caspase‐3 proteolysis of α‐spectrin after traumatic brain injury , 1998, Neuroreport.

[90]  R. Doctor,et al.  Degradation of spectrin and ankyrin in the ischemic rat kidney. , 1993, The American journal of physiology.

[91]  I. K. Berezesky,et al.  The Pathways of Cell Death: Oncosis, Apoptosis, and Necrosis , 1997, Toxicologic pathology.

[92]  R. Schnellmann,et al.  Proteinases in renal cell death. , 1996, Journal of toxicology and environmental health.

[93]  G. Gores,et al.  Induction of the mitochondrial permeability transition by protease activity in rats: a mechanism of hepatocyte necrosis. , 1996, Gastroenterology.

[94]  A. Chishti,et al.  Disruption of the Mouse μ-Calpain Gene Reveals an Essential Role in Platelet Function , 2001, Molecular and Cellular Biology.

[95]  S. Krajewski,et al.  Calpain and Mitochondria in Ischemia/Reperfusion Injury* , 2002, The Journal of Biological Chemistry.

[96]  D. Choi Calcium: still center-stage in hypoxic-ischemic neuronal death , 1995, Trends in Neurosciences.

[97]  R. Schnellmann,et al.  Calpains mediate acute renal cell death: role of autolysis and translocation. , 2001, American journal of physiology. Renal physiology.

[98]  M. Gnegy,et al.  Cytosolic Calmodulin Is Increased in SK‐N‐SH Human Neuroblastoma Cells Due to Release of Calcium from Intracellular Stores , 1998, Journal of neurochemistry.

[99]  J. Weinberg,et al.  Protection of ATP-depleted cells by impermeant strychnine derivatives: implications for glycine cytoprotection. , 2001, The American journal of pathology.

[100]  A. Burlingame,et al.  Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.

[101]  M. Tamai,et al.  Isolation and Characterization of E–64, a New Thiol Protease Inhibitor , 1978 .

[102]  E. Melloni,et al.  Acyl-CoA-binding Protein Is a Potent m-Calpain Activator* , 2000, The Journal of Biological Chemistry.

[103]  E. Melloni,et al.  Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator. , 1998, Biochemical and biophysical research communications.

[104]  S. Hoving,et al.  Breakdown of cytoskeletal proteins during meiosis of starfish oocytes and proteolysis induced by calpain. , 2000, Experimental cell research.

[105]  S. Kook,et al.  Degradation of focal adhesion proteins paxillin and p130cas by caspases or calpains in apoptotic rat-1 and L929 cells. , 2001, Biochemical and biophysical research communications.

[106]  M. Fehlings,et al.  Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury , 1999, Neuroscience.

[107]  D. Zhelev,et al.  Loss of plasma membrane structural support in ATP-depleted renal epithelia. , 1997, The American journal of physiology.

[108]  Zijian Xie,et al.  Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition , 1997, Oncogene.

[109]  J. Anagli,et al.  Ca(2+)-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form. , 1994, The Journal of biological chemistry.

[110]  B. Herman,et al.  Progression of subcellular changes during chemical hypoxia to cultured rat hepatocytes: A laser scanning confocal microscopic study , 1995, Hepatology.

[111]  J. Elce,et al.  Autolysis, Ca2+ Requirement, and Heterodimer Stability in m-Calpain* , 1997, The Journal of Biological Chemistry.

[112]  G. Gores,et al.  pH-dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. , 1993, The American journal of physiology.

[113]  K. Yoshida Myocardial ischemia-reperfusion injury and proteolysis of fodrin, ankyrin, and calpastatin. , 2000, Methods in molecular biology.

[114]  Junying Yuan,et al.  Cross-Talk between Two Cysteine Protease Families , 2000, The Journal of cell biology.

[115]  K. Wang,et al.  The calpain family and human disease. , 2001, Trends in molecular medicine.

[116]  W. Catterall,et al.  Differential Proteolysis of the Full‐Length Form of the L‐Type Calcium Channel α1 Subunit by Calpain , 1994, Journal of neurochemistry.

[117]  J. Farber,et al.  Calcium dependence of toxic cell death: a final common pathway. , 1979, Science.

[118]  KEVIN S. Lee,et al.  Neuroprotection With a Calpain Inhibitor in a Model of Focal Cerebral Ischemia , 1994, Stroke.

[119]  G. Gores,et al.  Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases. , 1998, Biochimica et biophysica acta.

[120]  D A Lauffenburger,et al.  Epidermal Growth Factor Receptor Activation of Calpain Is Required for Fibroblast Motility and Occurs via an ERK/MAP Kinase Signaling Pathway* , 2000, The Journal of Biological Chemistry.

[121]  R. Schnellmann,et al.  Progressive disruption of the plasma membrane during renal proximal tubule cellular injury. , 2001, Toxicology and applied pharmacology.

[122]  G. Miller,et al.  A novel low-affinity strychnine binding site on renal proximal tubules: role in toxic cell death. , 1993, Life sciences.

[123]  K. Wang,et al.  Activation of the Ca2+-ATPase of human erythrocyte membrane by an endogenous Ca2+-dependent neutral protease. , 1988, Archives of biochemistry and biophysics.

[124]  G. Guroff,et al.  A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN. , 1964, The Journal of biological chemistry.

[125]  F. Schottler,et al.  Neuronal recovery after moderate hypoxia is improved by the calpain inhibitor MDL28170 , 1997, Brain Research.

[126]  C. Edelstein,et al.  Calcium-mediated proximal tubular injury-what is the role of cysteine proteases? , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[127]  P. Wilson,et al.  Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: a role for cysteine proteases. , 1991, Cell biology international reports.

[128]  M. Yaqoob,et al.  The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[129]  P. D. Bell,et al.  ‘Oxidation Inhibits Substrate Proteolysis by Calpain I but Not Autolysis* , 1997, The Journal of Biological Chemistry.

[130]  M. Berridge Inositol trisphosphate and calcium signalling , 1993, Nature.

[131]  H. Sorimachi,et al.  Autolysis of Calpain Large Subunit Inducing Irreversible Dissociation of Stoichiometric Heterodimer of Calpain , 2000, Bioscience, biotechnology, and biochemistry.

[132]  H. Sorimachi,et al.  Calpain: new perspectives in molecular diversity and physiological‐pathological involvement , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[133]  K. Suzuki,et al.  In situ capture of mu-calpain activation in platelets. , 1993, The Journal of biological chemistry.

[134]  B. Trump,et al.  Cytosolic Ca2+ elevation and calpain inhibitors in HgCl2 injury to rat kidney proximal tubule epithelial cells. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.

[135]  K. Blomgren,et al.  Calpastatin Is Up-regulated in Response to Hypoxia and Is a Suicide Substrate to Calpain after Neonatal Cerebral Hypoxia-Ischemia* , 1999, The Journal of Biological Chemistry.

[136]  N. Carragher,et al.  Degraded Collagen Fragments Promote Rapid Disassembly of Smooth Muscle Focal Adhesions That Correlates with Cleavage of Pp125FAK, Paxillin, and Talin , 1999, The Journal of cell biology.

[137]  M. Aleo,et al.  Endoplasmic reticulum Ca2+ signaling and calpains mediate renal cell death , 2002, Cell Death and Differentiation.

[138]  R. Schnellmann,et al.  Calpain Mediates Progressive Plasma Membrane Permeability and Proteolysis of Cytoskeleton-Associated Paxillin, Talin, and Vinculin during Renal Cell Death , 2003, Journal of Pharmacology and Experimental Therapeutics.

[139]  T. Koh,et al.  Nitric oxide inhibits calpain-mediated proteolysis of talin in skeletal muscle cells. , 2000, American journal of physiology. Cell physiology.

[140]  T J Bucci,et al.  The Nomenclature of Cell Death: Recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists , 1999, Toxicologic pathology.

[141]  S. Javadov,et al.  Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. , 1998, Biochimica et biophysica acta.

[142]  G. Gao,et al.  N‐terminal cleavage of Bax by calpain generates a potent proapoptotic 18‐kDa fragment that promotes Bcl‐2‐independent cytochrome C release and apoptotic cell death , 2000, Journal of cellular biochemistry.

[143]  B. Bahr,et al.  Effect of glycine on prelethal and postlethal increases in calpain activity in rat renal proximal tubules. , 1997, Kidney international.

[144]  P. Devarajan,et al.  Identification of a Novel Ankyrin Isoform (AnkG190) in Kidney and Lung That Associates with the Plasma Membrane and Binds α-Na,K-ATPase* , 1998, The Journal of Biological Chemistry.

[145]  B. Herman,et al.  Blebbing, free Ca2+ and mitochondrial membrane potential preceding cell death in hepatocytes , 1987, Nature.

[146]  T. Graybill,et al.  Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. , 1995, Journal of medicinal chemistry.

[147]  D. Bozyczko‐Coyne,et al.  Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I. , 1997, Journal of medicinal chemistry.

[148]  E. Lunney,et al.  An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[149]  R. Schnellmann,et al.  Efficacy of novel calpain inhibitors in preventing renal cell death. , 2000, The Journal of pharmacology and experimental therapeutics.